Taken together, our results suggest that in the setting of reduced insulin administration, the frequency of hypoglycemia (once vs. twice daily) alters the capacity of the adrenal medulla to replenish its releasable pool of catecholamines and may thus represent a significant adrenal medullary contribution to the neurogenic component of the clinical syndrome of HAAF. This evidence concerns the gene INS and Hypoglycemia.